Last reviewed · How we verify
AK138D1
At a glance
| Generic name | AK138D1 |
|---|---|
| Sponsor | Akeso |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of AK138D1 in Advanced Malignant Tumors (PHASE1)
- A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AK138D1 CI brief — competitive landscape report
- AK138D1 updates RSS · CI watch RSS
- Akeso portfolio CI